A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration

Clinical trial NCT01089517 · COMPLETED

Trial details

NCT number: NCT01089517
Sponsor: Ophthotech Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Age-Related Macular Degeneration

Start date: 2010-03-01
Primary completion: 2012-06-01
Enrollment: 449

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.